Clinical Outcomes of Stereotactic Body Radiotherapy With Immediate Versus Delayed Hormone Therapy in Men With Oligometastatic Recurrence of Prostate Cancer
Stereotactic body radiotherapy (SBRT) with the delayed option of androgen deprivation therapy (ADT) is the current treatment paradigm in men relapsed with oligometastatic prostate cancer based on the outcome of a phase II randomised controlled study. The immediate (concomitant) use of ADT in this clinical setting potentially augments the efficacy of SBRT by improving systemic disease control. The aim of this study was to compare the clinical outcomes of these two treatment strategies.
Source: Clinical Oncology - Category: Radiology Authors: C.L. Chaw, N.M. deSouza, V. Khoo, Y.E. Suh, N. van As Tags: Original Article Source Type: research
More News: Cancer | Cancer & Oncology | Hormonal Therapy | Hormones | Prostate Cancer | Radiology | Study